AUG 24, 2026 · JOURNAL ARTICLE
Artificial intelligence–enabled electrocardiography for assessment of left ventricular systolic dysfunction in the era of foundation models
Frontiers in Cardiovascular Medicine
Rigorous review of multiple study designs including pragmatic randomized trials and external validation of FDA-cleared device, demonstrating consistent diagnostic accuracy and practice-level impact across diverse settings, though primary outcomes remain surrogate measures rather than hard clinical events.
Reported
Ejection fraction threshold (FDA-…≤40%
Geographic scope of external vali…four geographically diverse U.S. health sys…